Meyka Pro banner
Becton, Dickinson and Company

Becton, Dickinson and Company (BDXB) Stock Overview

Explore Becton, Dickinson and Company’s financial performance, market position, analyst ratings, and future outlook.

BDXBNYSE
HealthcareMedical - Instruments & Supplies
$48.16
$0.66(1.39%)
U.S. Market opens in 14h 25m

Becton, Dickinson and Company (BDXB)

Meyka AI Score

Z

Key Financials

Market Cap13.7B
P/E Ratio39.58
EPS (TTM)$6.33
ROE0.05%
Fundamental Analysis

AI Price Forecasts

1 MonthN/A
3 MonthsN/A
1 Year Target$36.97

BDXB Stock Analysis & Investment Overview (NYSE)

Our AI-powered analysis of Becton, Dickinson and Company (NYSE: BDXB) gives investors deep insight into how the stock performs on the NYSE exchange, its growth potential, and its market positioning. With a Meyka AI Score of B, Becton, Dickinson and Company's NYSE-listed shares demonstrate moderate investment characteristics based on our machine learning models.

The current technical analysis of BDXB on the NYSE shows an RSI of N/A, suggesting the stock is in a an undetermined condition. Our forecasting models predict a 12-month price target of $36.97 for the NYSE listing.

Key metrics behind Becton, Dickinson and Company's NYSE-traded stock include a P/E ratio of 39.58 and a market capitalization of 13.7B. Combined with our AI analysis, these give both institutional and retail investors a clear view of BDXB on the NYSE.

Price Performance (NYSE: BDXB)

1-Day Change
N/A
5-Day Change
N/A
1-Month Change
1.39%
3-Month Change
-3.51%
6-Month Change
-3.83%
Year-to-Date (YTD) Change
-4.33%
1-Year Change
-2.63%
3-Year Change
-9.47%
5-Year Change
11.69%
All-Time (Max) Change
11.69%

Contact Information

201 847 6800
1 Becton Drive, Franklin Lakes, NJ, 07417-1880

Company Facts

770,000 Employees
IPO DateMay 21, 2020
CountryUS

Frequently Asked Questions